Preventing adverse events of chemotherapy for gastrointestinal cancer by educating patients about the nocebo effect: a randomized-controlled trial

Table 3 Clinician-rated adverse events of chemotherapy at T2 and T3 according to Common Terminology Criteria for Adverse Events

AE adverse events, CG attention control group, EG nocebo education group, T2 10 days after onset of chemotherapy; T3 12 weeks after onset of chemotherapy. G1 Grade 1 “Mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated”, G2 Grade 2 “Moderate; minimal, local or non-invasive intervention indicated; limiting age-appropriate instrumental activities of daily living, G3 Grade 3 “Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self-care activities of daily living (defined by the National Institutes of Health, National Cancer Institute, 2009)

ISSN: 1471-2407